Clinical Trials in Salt Lake City

Showing 2581-2600 of 7,997 trials

ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer

NCT05824559

This is a Phase 1b open-label, multiple dose/schedule sequential study to determine the safety and efficacy of the oxidative phosphorylation (OxPhos) pathway inhibitor ME-344 in combination with bevacizumab in subjects with recurrent mCRC.

Colorectal Cancer

MEI Pharma, Inc.23 participantsStarted Aug 2023

Los Angeles, California, United States • Miami Beach, Florida, United States • Baltimore, Maryland, United States +4 more locations

COMPLETEDPhase 3< 1 mile

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

NCT03393520

This study will be conducted to evaluate the efficacy, safety, and tolerability of AVP-786 compared to placebo, for the treatment of agitation in participants with dementia of the Alzheimer's type.

Agitation in Patients With Dementia of the Alzheimer's Type

Otsuka Pharmaceutical Development & Commercialization, Inc.601 participantsStarted Oct 2017

Chandler, Arizona, United States • Gilbert, Arizona, United States • Phoenix, Arizona, United States +208 more locations

ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Find Trials by Condition in Salt Lake City

A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve

Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)

Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency

Hypofractionated Radiotherapy for the Treatment of Cervical or Endometrial Cancer

The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)

Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial

A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment

Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer

A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)

Oxulumis® Suprachoroidal Microcatherization of Triesence® in Diabetic Macular Edema

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC

A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg Ulcers

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies